Post by Tabita Watanga on Jul 12, 2016 13:40:22 GMT
Dual diagnosis
Dual diagnosis defined as the co-existence of mental illness and substance use (alcohol/ or other drug). Mental health and substance use has been identified as a very common problem in consumers presenting with mental illness. Alcohol and other drugs complicate assessment and management of mental illness. It is reported that consumers with dual diagnosis often do not receive optimal treatment due to exclusion and alienation of one problem until the other problem is treated. Therefore, consumers’ with dual diagnosis; mental illness and substance misuse are faced difficulties when accessing mental health services. Dual diagnosis has also been associated with a number of deaths such as suicide.
Consumers with dual diagnosis are expected often have poorer treatment outcomes and increased health risk. Suicide rate, high rate of unemployment, homelessness and incarceration are commonly associated with consumers diagnosed with dual diagnosis. More severe signs and symptoms, more prominent positive symptoms, increased hospitalization, poorer rehabilitation outcomes are also associated among consumers diagnosed with dual diagnosis.
Dual diagnosis approach to treatment objectives is to work with the consumer, treating both mental health and alcohol and drug problems, without sending them from one service to the other.
The recovery process can be prolonged and the rate of relapse increases. Withdrawal is another effect that is to be considered when consumers are admitted to an acute inpatient service. Treatment team referral to a specific dual diagnosis specialist while the consumer is an inpatient is beneficial when treating both mental illness and substance use. Self-harm, suicidal ideation and other symptoms associated with withdrawal such as hallucination require monitoring to reduce harm and relapse. Understanding phases of withdrawal, signs and symptom and medications is essential in treatment management.
Withdrawal scale assists in assessment; management and monitor symptoms needed of plan interventions.
Other treatment methods such as CBT, mindfulness, counseling, peer support groups and harm reduction are useful intervention.
References
MHPOD (cited 2016). www.vic.mhpod.gov.au/assets/php/player.php?a=12&scoid=114
Mental Illness Fellowship Victoria - for people with mental illness, their families and friends (cited 2016). Understanding dual diagnosis: mental illness and substance use. Retrieved from www.mifellowship.org/sites/default/files/styles/Fact%20Sheets/Understanding%20Dual%20Diagnosis.pdf
Dual diagnosis defined as the co-existence of mental illness and substance use (alcohol/ or other drug). Mental health and substance use has been identified as a very common problem in consumers presenting with mental illness. Alcohol and other drugs complicate assessment and management of mental illness. It is reported that consumers with dual diagnosis often do not receive optimal treatment due to exclusion and alienation of one problem until the other problem is treated. Therefore, consumers’ with dual diagnosis; mental illness and substance misuse are faced difficulties when accessing mental health services. Dual diagnosis has also been associated with a number of deaths such as suicide.
Consumers with dual diagnosis are expected often have poorer treatment outcomes and increased health risk. Suicide rate, high rate of unemployment, homelessness and incarceration are commonly associated with consumers diagnosed with dual diagnosis. More severe signs and symptoms, more prominent positive symptoms, increased hospitalization, poorer rehabilitation outcomes are also associated among consumers diagnosed with dual diagnosis.
Dual diagnosis approach to treatment objectives is to work with the consumer, treating both mental health and alcohol and drug problems, without sending them from one service to the other.
The recovery process can be prolonged and the rate of relapse increases. Withdrawal is another effect that is to be considered when consumers are admitted to an acute inpatient service. Treatment team referral to a specific dual diagnosis specialist while the consumer is an inpatient is beneficial when treating both mental illness and substance use. Self-harm, suicidal ideation and other symptoms associated with withdrawal such as hallucination require monitoring to reduce harm and relapse. Understanding phases of withdrawal, signs and symptom and medications is essential in treatment management.
Withdrawal scale assists in assessment; management and monitor symptoms needed of plan interventions.
Other treatment methods such as CBT, mindfulness, counseling, peer support groups and harm reduction are useful intervention.
References
MHPOD (cited 2016). www.vic.mhpod.gov.au/assets/php/player.php?a=12&scoid=114
Mental Illness Fellowship Victoria - for people with mental illness, their families and friends (cited 2016). Understanding dual diagnosis: mental illness and substance use. Retrieved from www.mifellowship.org/sites/default/files/styles/Fact%20Sheets/Understanding%20Dual%20Diagnosis.pdf